Cargando…

Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy

Fibrates lower triglycerides and raise HDL cholesterol in dyslipidemic patients, but show heterogeneous treatment response. We used k-means clustering to identify three representative NMR lipoprotein profiles for 775 subjects from the GOLDN population, and study the response to fenofibrate in corres...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Bochove, Kees, van Schalkwijk, Daniël B., Parnell, Laurence D., Lai, Chao-Qiang, Ordovás, José M., de Graaf, Albert A., van Ommen, Ben, Arnett, Donna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373573/ https://www.ncbi.nlm.nih.gov/pubmed/22719863 http://dx.doi.org/10.1371/journal.pone.0038072

Ejemplares similares

Lipoprotein Metabolism Indicators Improve Cardiovascular Risk Prediction
por: van Schalkwijk, Daniël B., et al.
Publicado: (2014)

Genetic Risk Scores Associated with Baseline Lipoprotein Subfraction Concentrations Do Not Associate with Their Responses to Fenofibrate
por: Frazier-Wood, Alexis C., et al.
Publicado: (2014)

Diagnostic markers based on a computational model of lipoprotein metabolism
por: van Schalkwijk, Daniël B, et al.
Publicado: (2011)

Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015)

Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate
por: Aslibekyan, Stella, et al.
Publicado: (2012)

TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate
por: Kabagambe, Edmond K, et al.
Publicado: (2009)

A clustering analysis of lipoprotein diameters in the metabolic syndrome
por: Frazier-Wood, Alexis C, et al.
Publicado: (2011)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
por: Wood, Alexis C, et al.
Publicado: (2011)

The PPAR Alpha gene is associated with triglyceride, low-density cholesterol, and inflammation marker response to fenofibrate intervention: The GOLDN Study
por: Frazier-Wood, A.C., et al.
Publicado: (2012)

Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials
por: Ye, Jiatao, et al.
Publicado: (2011)

Low density lipoprotein receptor related protein 1 variant interacts with saturated fatty acids in Puerto Ricans
por: Smith, Caren E., et al.
Publicado: (2013)

Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis
por: Oomen, Priscilla P., et al.
Publicado: (2023)

Dietary Medium Chain Fatty Acid Supplementation Leads to Reduced VLDL Lipolysis and Uptake Rates in Comparison to Linoleic Acid Supplementation
por: van Schalkwijk, Daniël B., et al.
Publicado: (2014)

Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome
por: Chan, Dick C., et al.
Publicado: (2009)

The impact of alcoholic drinks and dietary factors on epigenetic markers associated with triglyceride levels
por: Lai, Chao-Qiang, et al.
Publicado: (2023)

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
por: Kazemi, Moloud, et al.
Publicado: (2018)

Impact of Fenofibrate on Type 2 Diabetes Patients with Features of the Metabolic Syndrome: Subgroup Analysis From FIELD
por: Hermans, Michel P.
Publicado: (2010)

Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites
por: Mattei, Josiemer, et al.
Publicado: (2009)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

Answering biological questions: querying a systems biology database for nutrigenomics
por: Evelo, Chris T., et al.
Publicado: (2010)

Modulation by Dietary Fat and Carbohydrate of IRS1 Association With Type 2 Diabetes Traits in Two Populations of Different Ancestries
por: Zheng, Ju-Sheng, et al.
Publicado: (2013)

Cluster Analysis to Identify Possible Subgroups in Tinnitus Patients
por: van den Berge, Minke J. C., et al.
Publicado: (2017)

Data for GAW20: genome-wide DNA sequence variation and epigenome-wide DNA methylation before and after fenofibrate treatment in a family study of metabolic phenotypes
por: Aslibekyan, Stella, et al.
Publicado: (2018)

A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate
por: Kodera, Hitoshi, et al.
Publicado: (2017)

Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
por: Najafipour, Mostafa, et al.
Publicado: (2018)

Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy
por: Fu, Dongxu, et al.
Publicado: (2020)

Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network study
por: Ma, Yiyi, et al.
Publicado: (2015)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
por: Reyes-Soffer, Gissette, et al.
Publicado: (2013)

β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats
por: Ferreira, Ederlan S, et al.
Publicado: (2012)

The PLIN4 Variant rs8887 Modulates Obesity Related Phenotypes in Humans through Creation of a Novel miR-522 Seed Site
por: Richardson, Kris, et al.
Publicado: (2011)

Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge
por: Lai, Chao-Qiang, et al.
Publicado: (2016)

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010)

Genome-Wide Contribution of Genotype by Environment Interaction to Variation of Diabetes-Related Traits
por: Zheng, Ju-Sheng, et al.
Publicado: (2013)

Fibrane the reduced derivative of fenofibrate
por: Kotheimer, Amanda E., et al.
Publicado: (2019)

A Review of Time Courses and Predictors of Lipid Changes with Fenofibric Acid-Statin Combination
por: Filippatos, Theodosios D.
Publicado: (2012)

A Randomized Trial of Lipid Metabolism Modulation with Fenofibrate for Acute Coronavirus Disease 2019
por: Chirinos, Julio, et al.
Publicado: (2022)

Porous Nanostructure, Lipid Composition, and Degree of Drug Supersaturation Modulate In Vitro Fenofibrate Solubilization in Silica-Lipid Hybrids
por: Almasri, Ruba, et al.
Publicado: (2020)

Phenotypic flexibility as key factor in the human nutrition and health relationship
por: van Ommen, Ben, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gp9crt9rm4b46i7hl39r8hme1g